Research Article

Achievements of Diabetes Goals and Their Determinants in Type 2 Diabetic Patients Attending Outpatient Diabetic Clinic in Northern Ethiopia

Table 1

Proportion of type 2 diabetic patients with poor glycemic control according to the sociodemographic, lifestyle, and clinical characteristics, attending Ayder Referral Hospital.

Patient characteristics Total number
(), (%)
Mean glycemia
≥ 130 mg/dL
(), (%)
valueCurrent glycemia
≥ 130 mg/dL
, (%)
value

Age, mean + SD49.9 + 16.90.3649.9 + 16.90.68
 ≤30 years5 (2.6)3 (2.2)0.71 (0.07)0.04
 31–45 years43 (22.9)33 (24.3)29 (23.0)
 46–60 years88 (46.8)61 (44.9)65 (51.6)
 >60 years52 (27.7)39 (28.7)31 (24.6)
Sex: male, (%)104 (58.9)71 (52.2)0.1764 (50.8)0.08
Education, (%)
 Illiterate64 (34.0)49 (36.0)0.2847 (37.3)0.09
 Primary education38 (20.2)28 (20.5)22 (17.5)
 Secondary and above86 (45.7)59 (43.3)57 (45.2)
Marital status, (%),
 Single36 (19.1)27 (19.6)0.5124 (19.1)0.85
 Married152 (80.8)109 (80.4)102 (80.9)
Residency, (%)
 Rural32 (17.0)26 (19.1)0.2523 (18.3)0.6
 Urban156 (82.9)110 (80.9)103 (81.7)
Income (ETB), (%)
 None34 (18.1%)21 (15.4)0.920 (14.7)0.26
 <100050 (26.6)37 (27.2)36 (28.6)
 1000–250056 (29.8)44 (32.4)42 (33.3)
 >250048 (25.5)34 (25.0)28 (22.2)
Lifestyles, yes, (%)
 Smoking2 (15)2 (1.5)NA2 (1.5)
 Alcohol intake11 (5.9)7 (5.1)0.56 (4.8)
 Physical activity31 (16.5)21 (15.4)0.4717 (13.5)0.11
 Dietary restriction124 (66.0)86 (63.2)0.3179 (62.7)0.28
Self-monitoring practices, yes, (%)21 (11.1)15 (11.0)0.6412 (9.5)0.84
Number of visits in 6 months
 3-4 times106 (56.4)75 (55.1)0.5876 (60.3)0.12
 5-6 times82 (43.6)61 (44.9)50 (39.7)
Duration of diabetes in years, mean + SD6.5 + 6.8-0.0146.5 + 6.80.21
 <5 years94 (50.0)62 (45.6)0.00760 (47.6)0.14
 5–10 years50 (26.6)39 (28.7)36 (28.6)
 >10 years44 (23.4)35 (25.7)30 (23.8)
Glycemic variability ≥ 2593 (49.5)77 (56.6)0.00262 (49.2)0.91
Large SD (SD 3 > mean)61 (32.44)51 (37.5)0.0239 (31.0)0.53
Diabetes drugs, (%)
 OHA104 (55.3)73 (53.7)0.6768 (54.0)0.14
 Insulin only71 (37.8)54 (39.7)46 (36.5)
 Combination therapy13 (6.9)9 (6.6)12 (9.5)
Use of other drugs, yes, (%)76 (40.4)55 (40.4)0.9953 (42.1)0.51
Presence of comorbidities, yes, (%)128 (68.1)93 (68.4)0.8885 (67.5)0.79
BMI ≥ 2563 (33.5)41 (30.1)0.0639 (31.0)0.23
Dyslipidemia110 (58.5)85 (62.5)0.1080 (63.5)0.04
Hypertension98 (52.1)70 (51.5)0.5965 (51.6)0.7

SD: standard deviation; ETB: Ethiopian Birr; OHA; oral hypoglycemic agent, BMI: body mass index. values were calculated using chi-square test.